Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo

Microcirculation

Volumn 8, Issue 4, 2001, Pages 229-241

  Milkiewicz, M ^a   Brown, M D ^a   Egginton, S ^a   Hudlicka, O ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Capillary growth; Electrical stimulation; Immunohistochemistry; Prazosin; Proliferating cell nuclear antigen (PCNA); Red blood cell velocity; VEGF A

Indexed keywords

TRIXIS;

ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENT; CYCLINE; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PRAZOSIN; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; BLOOD FLOW; CAPILLARY; CHEMISTRY; DRUG EFFECT; ELECTROSTIMULATION; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; MICROCIRCULATION; PHYSIOLOGY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULARIZATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CAPILLARIES; ELECTRIC STIMULATION; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MICROCIRCULATION; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PRAZOSIN; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035433215     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800074     Document Type: Article

References (53)

1. Alon T, Hemo A, Itin A, Pe'er J, Stone J, Keshet E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine 1:1024-1028.
2. Anderson SI, Hudlicka O, Brown MD. (1997). Capillary red blood cell flow and activation of white blood cells in chronic muscle ischemia in the rat. Am J Physiol 272:H2757-H2764.
3. Ando J, Nomura H, Kamiya A. (1987). The effect of fluid shear stress on the migration and proliferation of cultured endothelial cells. Microvasc Res 33:62-70.
4. Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, Kraus WE. (1998). Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol 274.-H860-H867.
5. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. (1998). Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40-50.
6. Benoit H, Jordan M, Wagner H, Wagner PD. (1999). Effect of NO, vasodilator prostaglandins and adenosine on skeletal muscle angiogenic growth factor gene expression. J Appl Physiol 86:1513-1518.
7. Berse B, Brown LF, Van den Water L, Dvorak HF, Senger DR. (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3:211-220.
8. Boehringer Mannheim. (1996). Non Radioactive In Situ Hybridization Appplication Manual. Boehringer Mannheim GmbH Biochemica. Mannheim. 126-131.
9. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81:355-361.
10. Brown MD, Hudlicka O, Makki RF, Weiss JB. (1995). Low-molecular-mass-endothelial cell-stimulating angiogenic factor in relation to capillary growth induced in rat skeletal muscle by low-frequency electrical stimulation, Int J Microcirc 15:111-116.
11. Brown MD, Walter H, Hansen-Smith FM, Hudlicka O, Egginton S. (1998). Lack of involvement of basic fibroblast growth factor (FGF-2) in capillary growth in skeletal muscles exposed to long-term contractile activity. Angiogenesis 2:81-91.
12. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
13. Castilla MA, Arroyo MV, Aceituno E, Aragoncillo P, Gonzales-Pacheco FR, Tezeiro E, Bragado R, Caramelo C. (1999). Disruption of cadherin-related junctions triggers autocrine expression of vascular endothelial growth factor in bovine aortic endothelial cells: effects on proliferation and death resistance. Circ Res 85:1132-1138.
14. Davies PF. (1995). Flow mediated mechanotransduction. Physiol Rev 75:519-560.
15. Dawson JM. (1987). Ph.D. Thesis, University of Birmingham.
16. Dawson JM, Hudlicka O. (1989). The effect of longterm activity on the microvasculature of rat glycolytic skeletal muscle. Int J Microcirc 8:53-69.
17. Dawson JM, Hudlicka O. (1990). The effects of longterm administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23:913-920.
18. Dawson JM, Hudlicka O. (1993). Can changes in microcirculation explain capillary growth in skeletal muscle? Int J Exp Path 74:65-71.
19. Dawson JM, Tyler KR, Hudlicka O. (1987). A comparison of the microcirculation in rat fast glycolytic and slow oxidative muscles at rest and during contractions. Microvasc Res 33:167-182.
20. Egginton S, Hudlicka O. (1999). Early changes in performance, blood flow and capillary fine structure in rat fast muscles induced by electrical stimulation. J Physiol 515:265-275.
21. Egginton S, Zhou A-L, Brown MD, Hudlicka O. (2000). The role of pericytes in controlling angiogenesis in vivo. In: Angiogenesis: From the Molecular to Integrative Pharmacology (ME Maragoudakis, Ed.) Adv Exp Med Biol 476. Kluwer Academic J Plenum Publishers. New York. 81-99.
22. Egginton S, Zhou A-L, Brown MD, Hudlicka O. (2001). Unorthodox angiogenesis in skeletal muscle. Cardiovasc, Res 49:634-646.
23. Fulgenzi G, Graciotti L, Collis MG, Hudlicka O. (1998). The effect of alpha-1 adrenoceptor antagonist prazosin on capillary supply, blood flow and performance in a rat model of chronic muscle ischaemia. Eur J Vasc Endovasc Surg 16:71-77.
24. Can L. Miocic M, Doroudi R, Selin-Sjgren L, Jern S. (2000). Distinct regulation of vascular endothelial growth in intact human conduit vessels exposed to laminar fluid shear stress and pressure. Biochem Biophys Res Comm 272:490-496.
25. Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD. (2000). Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol 88:1192-1198.
26. Grimm RH. (1991). Antihypertensive therapy: taking lipids into consideration. Am Heart J 122:910-918.
27. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti G. (1997). Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci USA 94:12112-12116.
28. Gudi S, Nolan JP, Frangos JA. (1998). Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition. Proc Nat Acad Sci USA 95:2525-2519.
29. Gustafson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ. (1999). Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol 276:H679-H685.
30. Haas T, Milkiewicz M, Davis SJ, Zhou A-L, Egginton S, Brown MD, Madri JA, Hudlicka O. (2000). MMP-2 and MT1-MMP are upregulated and matrix metalloproteinase activity is required for adaptive angiogenesis in rat skeletal muscle. Am J Physiol 279:H1540-H1549.
31. Hang J, Kong L, Gu JW, Adair TH. (1995). VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol 269:H1827-H1831.
32. Hawker MJ, Egginton S. (1999). The effect of stimulation frequency on blood flow in rat fast skeletal muscles. Exp Physiol 84:941-946.
33. Hudlicka O. (1991). What makes blood vessels grow? J Physiol 444:1-24.
34. Hudlicka O, Brown MD, Egginton S. (1992). Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72:369-417.
35. Hudlicka O, Brown MD, Silgram H. (2000). Inhibition of capillary growth in chronically stimulated rat muscles by NG-nitro-L-arginine, nitric oxide synthase inhibitor. Microvasc Res 59:45-51.
36. Li J, Hampton T, Morgan JP, Simons M. (1997). Stretch-induced VEGF expression in the heart. J Clin Invest 100:18-24.
37. Milkiewicz M, Hudlicka O, Brown MD. (2000). Hypoxia as a stimulus for vascular endothelial growth factor expression and capillary growth in rat and rabbit skeletal muscle during chronic stimulation. J Physiol (London) 523P:147P.
38. Miquerol L, Gerstenstein M, Harpal K, Rossant J, Nagy A. (1999) Multiple development roles of VEGF suggested by a Lac Z-tagged allele. Develop Biol 212: 307-322.
39. Myrhage R, Hudlicka O. (1978). Capillary growth in chronically stimulated adult skeletal muscle as studied by intravital microscopy and histological methods in rabbits and rats. Microvasc Res 16:73-90.
40. Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR, Jo H. (1998). Plasma membrane cholesterol is a key molecule in shear stressdependent activation of extracellular signal-related kinase. J Biol Chem 272:32304-32311.
41. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. (1995). Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 43:381-389.
42. Richardson RS, Wagner H, Mudaliar SRD, Henry R, Noyszewski EA, Wagner PD. (1999). Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol 277: H2247-H2252.
43. Roca J, Gavin TP, Jordan M, Siafakas N, Wagner H, Benoit H, Breen E, Wagner PD. (1998). Angiogenic growth factor mRNA responses to passive and contraction-induced hyperperfusion in skeletal muscles. J Appl Physiol 85:1142-1149.
44. Sarelius IH. (1993). Cell and oxygen flow in arterioles controlling capillary perfusion. Am J Physiol 264:H1682-H1687.
45. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro AC, Rifkin DB, Mignatti P. (1998). Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673.
46. Seko Y, Seko Y, Fujikura H, Pang J, Tokoro T, Shimokawa H. (1999). Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 40:3287-3291.
47. Skorjanc D, Jaschinski F, Heine G, Pette D. (1998). Sequential increases in capillarization and mitochondrial enzymes in low-frequency-stimulated rabbit muscle. Am J Physiol 274:C810-C818.
48. Steinbrech DS, Longaker MT, Mehrara BJ, Saadeh PB, Chin GS, Garrets RP, Chau DC, Rowe NM, Gittes GK. (1999). Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation. J Surg Res 84:127-133.
49. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP. (1996). Adenosine mediates hypoxic, induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37: 2165-2176.
50. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ. (1999). Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85:192-198.
51. Zhou A-L, Egginton S, Hudlicka O, Brown MD. (1998). Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with alpha-1 antagonist prazosin. Cell Tissue Res 293:293-303.
52. Ziada A, Hudlicka O, Tyler KR. (1989). The effect of long-term administration of a1-blocker prazosin on capillary density in cardiac and skeletal muscle. Pflügers Arch 415:355-360.
53. Ziehe M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ, Bicknell R. (1997). Nitric oxide synthase lies downstream from vascular endothelium growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634.